Evidence map›Paper›PMID 36739457›Full record

ArticleScientific reports2023

Circulating microvesicles correlate with radiation proctitis complication after radiotherapy.

Alexandre Ribault, Mohamed Amine Benadjaoud, Claire Squiban, Laurent Arnaud, Coralie Judicone, Aurélie S Leroyer, Alexandra Rousseau, Christelle Huet, Chandan Guha, Marc Benderitter and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Radiation proctitis as a differential of lower GIT bleeding in Nigeria: A case series.Nigerian medical journal : journal of the Nigeria Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Alexandre Ribault *Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Mohamed Amine Benadjaoud *Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France. mohamedamine.benadjaoud@irsn.fr.
Claire SquibanInstitut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Laurent ArnaudDepartment of Hematology, Biogenopole, CHU La Timone, APHM, Marseille, France.
Coralie JudiconeDepartment of Hematology, Biogenopole, CHU La Timone, APHM, Marseille, France.
Aurélie S LeroyerAix-Marseille University, C2VN, INSERM 1263, INRAE 1260, Marseille, France.
Alexandra RousseauHôpital Saint Antoine, APHP, Unité de Recherche Clinique de L'Est Parisien (URC-Est), Paris, France.
Christelle HuetInstitut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Chandan GuhaDepartment of Radiation Oncology, Albert Einstein College of Medicine, New York, USA.
Marc BenderitterInstitut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Romaric LacroixDepartment of Hematology, Biogenopole, CHU La Timone, APHM, Marseille, France.
Stephane FlamantInstitut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Emily I ChenDepartment of Pharmacology, Columbia University Medical Center, New York, USA.
Jean-Marc SimonHôpital Pitié-Salpêtrière, Sorbonne Université́, Service d'Oncologie Radiothérapie, Assistance Publique-Hôpitaux de Paris (APHP), 75013, Paris, France.
Radia TamaratInstitut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France. radia.tamarat@irsn.fr.
Institut de Radioprotection et de Sûreté Nucléaire · FRAlphabio · FRAlbert Einstein College of Medicine · USColumbia University Irving Medical Center · USHôpital Saint-Antoine · FRInserm · FRSorbonne Université · FR

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FORNACE, ALBERT J · 2005 to 2024
$105.4M
NCI NIH HHS P30 CA013696NIAID NIH HHS U19 AI067773
6 · The paper itself

Abstract

In a large retrospective study, we assessed the putative use of circulating microvesicles (MVs), as innovative biomarkers of radiation toxicity in a cohort of 208 patients with prostate adenocarcinoma overexposed to radiation. The level of platelet (P)-, monocyte (M)- and endothelial (E)-derived MVs were assessed by flow cytometry. Rectal bleeding toxicity scores were collected at the time of blood sampling and during the routine follow-up and were tested for association with MVs using a multivariate logistic regression. MVs dosimetric correlation was investigated using dose volume histograms information available for a subset of 36 patients. The number of PMVs was significantly increased in patients with highest toxicity grades compared to lower grades. Risk prediction analysis revealed that increased numbers of PMVs, and an increased amount of MMVs relative to EMVs, were associated with worst rectal bleeding grade compared to the time of blood sampling. Moreover, a significant correlation was found between PMV and MMV numbers, with the range of doses up to the median exposure (40 Gy) of bladder/rectum and anterior rectal wall, respectively. MVs could be considered as new biomarkers to improve the identification of patients with high toxicity grade and may be instrumental for the prognosis of radiation therapy complications.

Indexed as

GastritisProctitisProstatic NeoplasmsRadiation InjuriesRectumHumansMaleRadiotherapy DosageRetrospective Studies

Identifiers

PMID36739457
PMCPMC9899237
OpenAlexW4319163929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.